文献
J-GLOBAL ID:201802279122729826
整理番号:18A0280601
FDA認可薬物ソホスブビルはジカウイルス感染を阻害する【Powered by NICT】
The FDA-approved drug sofosbuvir inhibits Zika virus infection
著者 (11件):
Bullard-Feibelman Kristen M.
(Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA)
,
Govero Jennifer
(Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA)
,
Zhu Zhe
(Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA)
,
Salazar Vanessa
(Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA)
,
Veselinovic Milena
(Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA)
,
Diamond Michael S.
(Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA)
,
Diamond Michael S.
(Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA)
,
Diamond Michael S.
(Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA)
,
Diamond Michael S.
(The Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO, USA)
,
Geiss Brian J.
(Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA)
,
Geiss Brian J.
(School of Biomedical Engineering, Colorado State University, Fort Collins, CO, USA)
資料名:
Antiviral Research
(Antiviral Research)
巻:
137
ページ:
134-140
発行年:
2017年
JST資料番号:
D0654B
ISSN:
0166-3542
CODEN:
ARSRDR
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)